Form 4: Centene Director Christopher Coughlin Reports Acquisition of Common Stock
SEC Form 4 Filing
Director Christopher Coughlin reports acquiring 388.551 shares of Centene Corp common stock on March 31, 2024.
Summary
- On March 31, 2024, Christopher J Coughlin, a director of Centene Corp, acquired 388.551 shares of common stock at $0 per share.
- Following the transaction, Coughlin directly owns 22,587.926 shares of Centene Corp common stock, which includes 2,947 shares of restricted stock subject to vesting requirements.
- Coughlin also owns options to buy 10,000 shares of common stock with an exercise price of $80.57, exercisable from February 7, 2025, to February 7, 2032.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock acquisition by a director. The acquisition itself is a slightly positive signal, but the form is simply a mandatory filing.
Positives
- A director's acquisition of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors for signals about management's view of the company's prospects.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | Date of transaction: Acquisition of common stock. |
| 02/07/2025 | Earliest date Common Stock Options are exercisable |
| 02/07/2032 | Expiration date of Common Stock Options |
| 04/02/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.